{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:01:28Z","timestamp":1785456088604,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johns Hopkins Center for Psychedelic and Consciousness Research by Tim Ferriss, Matt Mullenweg, Blake Mycoskie, Craig Nerenberg, and the Steven and Alexandra Cohen Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cannabis is among the most widely consumed psychoactive substances, with increasing consumption due to growing legalization for medical and non-medical use. As access expands, healthcare providers are faced with clinical challenges, despite variability in knowledge and attitudes on cannabis use in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an anonymous, cross-sectional web-based survey of U.S. healthcare professionals to assess knowledge and attitudes regarding cannabis use in clinical settings. Participants completed demographic items, self-report measures of cannabis-related beliefs and attitudes, and an objective knowledge assessment covering cannabis therapeutic indications, risks, and mechanisms of action. Descriptive analyses were conducted, followed by multivariable linear regression models examining whether demographic characteristics, knowledge, or concerns predicted openness to the clinical use of cannabis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 879 respondents (71% female; 86% White; mean age\u2009=\u200946\u00a0years), 89% reported having patients who use cannabis. The sample included mental health professionals (29%), registered nurses (25%), physicians (18%), and advanced practice providers (15%). Participants rated their self-reported knowledge highest for cannabis\u2019s risks (mean\u2009=\u20094.1\/5), followed by therapeutic indications (mean\u2009=\u20094.0\/5), and mechanisms of action (mean\u2009=\u20093.5\/5). In contrast, objective knowledge check scores were generally low across these domains (13\u201364% correct). Personal experience (76%) and popular media (73%) were the most endorsed sources of cannabis-related knowledge. Overall, most respondents (87%) endorsed the therapeutic promise of cannabis, 74% reported openness to recommending medical cannabis, and 95% supported its legal medical use. Commonly cited concerns regarding clinical use of cannabis included lack of trained providers (35%), possible patient exploitation (22%), recreational misuse (21%), and risk of psychosis (20%). Greater openness to clinical use was associated with higher self-rated knowledge, younger age, professional role, and lower levels of concern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although most respondents reported having patients who use cannabis and were largely supportive of medical cannabis use, objective knowledge gaps and limited formal training were evident. These findings suggest a need for structured clinical training on cannabis pharmacology, dosing, contraindications, and legal and ethical frameworks, as well as better monitoring of cannabis use to support safe and informed patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-026-00450-8","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:23:49Z","timestamp":1780039429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge, attitudes, and concerns about medical cannabis among U.S. healthcare professionals"],"prefix":"10.1186","volume":"8","author":[{"given":"Lakshmi","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Austin","family":"Zamarripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tory R.","family":"Spindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Vandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Garcia-Romeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"5","key":"450_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/can.2021.0097","volume":"6","author":"S Babalonis","year":"2021","unstructured":"Babalonis S, Raup-Konsavage WM, Akpunonu PD, Balla A, Vrana KE. \u03948-THC: legal status, widespread availability, and safety concerns. Cannabis Cannabinoid Res. 2021;6(5):362\u20135.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"6","key":"450_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1124\/dmd.122.001128","volume":"51","author":"S Bansal","year":"2023","unstructured":"Bansal S, Ladumor MK, Paine MF, Unadkat JD. A physiologically-based pharmacokinetic model for cannabidiol in healthy adults, hepatically-impaired adults, and children. Drug Metab Dispos. 2023;51(6):743\u201352.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"450_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13187-024-02484-z","volume":"40","author":"A Baral","year":"2025","unstructured":"Baral A, Diggs BNA, Greengold J, Foronda C, Anglade D, Camacho-Rivera M, et al. State of the science: health care provider communication of cannabis use among adults living with cancer. J Cancer Educ. 2025;40(3):329\u201347.","journal-title":"J Cancer Educ"},{"issue":"1","key":"450_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13722-015-0032-7","volume":"10","author":"KA Belendiuk","year":"2015","unstructured":"Belendiuk KA, Baldini LL, Bonn-Miller MO. Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addict Sci Clin Pract. 2015;10(1):10.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"450_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s42238-021-00073-1","volume":"3","author":"A Bhaskar","year":"2021","unstructured":"Bhaskar A, Bell A, Boivin M, Briques W, Brown M, Clarke H, et al. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res. 2021;3(1):22.","journal-title":"J Cannabis Res"},{"issue":"1","key":"450_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12916-022-02459-1","volume":"20","author":"A Bilbao","year":"2022","unstructured":"Bilbao A, Spanagel R. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med. 2022;20(1):259.","journal-title":"BMC Med"},{"issue":"3","key":"450_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1037\/pha0000682","volume":"32","author":"MO Bonn-Miller","year":"2024","unstructured":"Bonn-Miller MO, Feldner MT, Bynion TM, Eglit GM, Brunstetter M, Kalaba M, et al. A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. Exp Clin Psychopharmacol. 2024;32(3):277.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"450_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1049909115604669","volume":"34","author":"BH Carlini","year":"2017","unstructured":"Carlini BH, Garrett SB, Carter GT. Medicinal cannabis: a survey among health care providers in Washington State. Am J Hosp Palliat Med. 2017;34(1):85\u201391.","journal-title":"Am J Hosp Palliat Med"},{"key":"450_CR9","unstructured":"CDC. Cannabis and Public Health. 2024. Cannabis Facts and Stats. Available from: https:\/\/www.cdc.gov\/cannabis\/data-research\/facts-stats\/index.html. Cited 2025 Jan 20."},{"issue":"5","key":"450_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/cpt.1381","volume":"105","author":"K Cohen","year":"2019","unstructured":"Cohen K, Weizman A, Weinstein A. Positive and negative effects of cannabis and cannabinoids on health. Clin Pharmacol Ther. 2019;105(5):1139\u201347.","journal-title":"Clin Pharmacol Ther"},{"key":"450_CR11","doi-asserted-by":"crossref","unstructured":"Crippa JA, Guimar\u00e3es FS, Campos AC, Zuardi AW. Translational investigation of the therapeutic potential of cannabidiol (CBD): Toward a New Age. Front Immunol. 2018;9.\u00a0Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2018.02009\/full.\u00a0Cited 2025 Mar 26.","DOI":"10.3389\/fimmu.2018.02009"},{"issue":"1","key":"450_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s42238-025-00321-8","volume":"7","author":"SP Cronin","year":"2025","unstructured":"Cronin SP, Cruz J, Cameron E, Azemar S, Dudley S, Largent-Milnes TM, et al. \u201cIt\u2019s legal, now what?\u201d development, implementation, and evaluation of interdisciplinary cannabis education for healthcare trainees. J Cannabis Res. 2025;7(1):68.","journal-title":"J Cannabis Res"},{"issue":"1","key":"450_CR13","doi-asserted-by":"publisher","first-page":"16163","DOI":"10.1038\/s41598-024-66879-0","volume":"14","author":"C Cuttler","year":"2024","unstructured":"Cuttler C, Stueber A, Cooper ZD, Russo E. Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial. Sci Rep. 2024;14(1):16163.","journal-title":"Sci Rep"},{"issue":"7","key":"450_CR14","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1371\/journal.pmed.0050141","volume":"5","author":"L Degenhardt","year":"2008","unstructured":"Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5(7):e141.","journal-title":"PLoS Med"},{"issue":"11","key":"450_CR15","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/bcp.13695","volume":"84","author":"LM Dryburgh","year":"2018","unstructured":"Dryburgh LM, Bolan NS, Grof CPL, Galettis P, Schneider J, Lucas CJ, et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharmacol. 2018;84(11):2468\u201376.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"450_CR16","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1111\/jgh.16730","volume":"39","author":"L Eadie","year":"2024","unstructured":"Eadie L, Lo LA, Boivin M, Deol JK, MacCallum CA. Clinical guidance for cannabidiol\u2010associated hepatotoxicity: a narrative review. J Gastroenterol Hepatol. 2024;39(12):2522\u201332.","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"450_CR17","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.mayocp.2018.09.005","volume":"93","author":"JO Ebbert","year":"2018","unstructured":"Ebbert JO, Scharf EL, Hurt RT. Medical cannabis. Mayo Clin Proc. 2018;93(12):1842\u20137.","journal-title":"Mayo Clin Proc"},{"key":"450_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neubiorev.2019.09.036","volume":"107","author":"AM Freeman","year":"2019","unstructured":"Freeman AM, Petrilli K, Lees R, Hindocha C, Mokrysz C, Curran HV, et al. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neurosci Biobehav Rev. 2019;107:696\u2013712.","journal-title":"Neurosci Biobehav Rev"},{"key":"450_CR19","doi-asserted-by":"publisher","first-page":"158110","DOI":"10.1016\/j.scitotenv.2022.158110","volume":"851","author":"H Gardener","year":"2022","unstructured":"Gardener H, Wallin C, Bowen J. Heavy metal and phthalate contamination and labeling integrity in a large sample of US commercially available cannabidiol (CBD) products. Sci Total Environ. 2022;851:158110.","journal-title":"Sci Total Environ"},{"key":"450_CR20","unstructured":"Haley DF, So-Armah K, Justice AC, Kidwai-Khan F, Xuan Z, Adams RS, et al. Cannabis use disorder among people with and without HIV. J Addict Med. 2024;10-1097."},{"issue":"2","key":"450_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00406-024-01880-2","volume":"275","author":"E Hoch","year":"2025","unstructured":"Hoch E, Volkow ND, Friemel CM, Lorenzetti V, Freeman TP, Hall W. Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. Eur Arch Psychiatry Clin Neurosci. 2025;275(2):281\u201392.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"10","key":"450_CR22","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dc16-0650","volume":"39","author":"KA Jadoon","year":"2016","unstructured":"Jadoon KA, Ratcliffe SH, Barrett DA, Thomas EL, Stott C, Bell JD, et al. Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study. Diabetes Care. 2016;39(10):1777\u201386.","journal-title":"Diabetes Care"},{"issue":"4","key":"450_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/can.2021.0032","volume":"7","author":"DJ Kruger","year":"2022","unstructured":"Kruger DJ, Mokbel MA, Clauw DJ, Boehnke KF. Assessing health care providers\u2019 knowledge of medical cannabis. Cannabis Cannabinoid Res. 2022;7(4):501\u20137.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"450_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2105\/AJPH.2021.306586","volume":"112","author":"MD Livingston","year":"2022","unstructured":"Livingston MD, Walker A, Cannell MB, Rossheim ME. Popularity of Delta-8 THC on the internet across US states, 2021. Am J Public Health. 2022;112(2):296\u20139.","journal-title":"Am J Public Health"},{"key":"450_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","volume":"49","author":"CA MacCallum","year":"2018","unstructured":"MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12\u20139.","journal-title":"Eur J Intern Med"},{"key":"450_CR26","doi-asserted-by":"crossref","unstructured":"Marcu J, Schechter JB. The Landscape of Cannabis Education. In: Marusak H, editor. Cannabis and the Developing Brain. Cham: Springer Nature Switzerland; 2025. p. 597\u2013622.\u00a0Available from: https:\/\/link.springer.com\/10.1007\/978-3-031-87990-6_25. Cited 2025 Oct 15.","DOI":"10.1007\/978-3-031-87990-6_25"},{"key":"450_CR27","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.dadr.2024.100253","volume":"12","author":"DT Mattingly","year":"2024","unstructured":"Mattingly DT, Richardson MK, Hart JL. Prevalence of and trends in current cannabis use among US youth and adults, 2013\u20132022. Drug Alcohol Depend Rep. 2024;12:100253.","journal-title":"Drug Alcohol Depend Rep"},{"key":"450_CR28","doi-asserted-by":"crossref","unstructured":"Mead A. Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States. Front Plant Sci. 2019;10.\u00a0Available from: https:\/\/www.frontiersin.org\/journals\/plant-science\/articles\/10.3389\/fpls.2019.00697\/full. Cited 2025 Mar 26.","DOI":"10.3389\/fpls.2019.00697"},{"issue":"1","key":"450_CR29","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.1111\/ijn.12836","volume":"27","author":"S Melnikov","year":"2021","unstructured":"Melnikov S, Aboav A, Shalom E, Phriedman S, Khalaila K. The effect of attitudes, subjective norms and stigma on health\u2010care providers\u2019 intention to recommend medicinal cannabis to patients. Int J Nurs Pract. 2021;27(1):e12836.","journal-title":"Int J Nurs Pract"},{"key":"450_CR30","doi-asserted-by":"publisher","unstructured":"NASEM. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington (DC): National Academies Press (US); 2017. (The National Academies Collection: Reports funded by National Institutes of Health). https:\/\/doi.org\/10.17226\/24625. Cited 2025 Oct 10.","DOI":"10.17226\/24625"},{"key":"450_CR31","unstructured":"Patton DV. A History of United States Cannabis Law. J Law Health. 2021;34(1):1-30."},{"issue":"1","key":"450_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/add.16663","volume":"120","author":"SC Pessar","year":"2025","unstructured":"Pessar SC, Smart R, Naimi T, Lira M, Blanchette J, Boustead A, et al. The association between state cannabis policies and cannabis use among adults and youth, United States, 2002\u20132019. Addiction. 2025;120(1):164\u201370.","journal-title":"Addiction"},{"issue":"1","key":"450_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12875-019-0906-y","volume":"20","author":"LM Philpot","year":"2019","unstructured":"Philpot LM, Ebbert JO, Hurt RT. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam Pract. 2019;20(1):17.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"450_CR34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.amepre.2023.03.005","volume":"65","author":"TG Rhee","year":"2023","unstructured":"Rhee TG, Rosenheck RA. Increasing use of cannabis for medical purposes among U.S. residents, 2013\u20132020. Am J Prev Med. 2023;65(3):528\u201333.","journal-title":"Am J Prev Med"},{"issue":"1","key":"450_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/JXX.0000000000000590","volume":"34","author":"J Rice","year":"2022","unstructured":"Rice J, Hildebrand A, Waslo CS, Cameron MH, Jones KD. Cannabis for medical purposes: a cross-sectional analysis of health care professionals\u2019 knowledge. J Am Assoc Nurse Pract. 2022;34(1):100\u20136.","journal-title":"J Am Assoc Nurse Pract"},{"issue":"7","key":"450_CR36","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","volume":"163","author":"EB Russo","year":"2011","unstructured":"Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid\u2010terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344\u201364.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"450_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s42238-024-00242-y","volume":"6","author":"E Russo","year":"2024","unstructured":"Russo E, Agredano PM, Flachenecker P, Lawthom C, Munro D, Hindocha C, et al. The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products. J Cannabis Res. 2024;6(1):32.","journal-title":"J Cannabis Res"},{"key":"450_CR38","doi-asserted-by":"publisher","first-page":"e072348","DOI":"10.1136\/bmj-2022-072348","volume":"382","author":"M Solmi","year":"2023","unstructured":"Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, et al. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ. 2023;382:e072348.","journal-title":"BMJ"},{"key":"450_CR39","unstructured":"US. H.R.2 - 115th Congress (2017\u20132018): Agriculture Improvement Act of 2018. 2018 Available from: https:\/\/www.congress.gov\/bill\/115th-congress\/house-bill\/2. Cited 2025 Oct 7."},{"issue":"3","key":"450_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","volume":"73","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiat. 2016;73(3):292\u20137.","journal-title":"JAMA Psychiat"},{"key":"450_CR41","doi-asserted-by":"publisher","first-page":"107258","DOI":"10.1016\/j.addbeh.2022.107258","volume":"129","author":"E Wadsworth","year":"2022","unstructured":"Wadsworth E, Craft S, Calder R, Hammond D. Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: a systematic review. Addict Behav. 2022;129:107258.","journal-title":"Addict Behav"},{"issue":"3","key":"450_CR42","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/ijerph19031850","volume":"19","author":"D Wallis","year":"2022","unstructured":"Wallis D, Coatsworth JD, Mennis J, Riggs NR, Zaharakis N, Russell MA, et al. Predicting self-medication with cannabis in young adults with hazardous cannabis use. Int J Environ Res Public Health. 2022;19(3):1850.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"450_CR43","doi-asserted-by":"publisher","first-page":"28022","DOI":"10.1038\/s41598-024-78736-1","volume":"14","author":"E Wang","year":"2024","unstructured":"Wang E, Mathai DS, Gukasyan N, Nayak S, Garcia-Romeu A. Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among US healthcare professionals. Sci Rep. 2024;14(1):28022.","journal-title":"Sci Rep"},{"issue":"1","key":"450_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s42238-021-00100-1","volume":"3","author":"JM Weisman","year":"2021","unstructured":"Weisman JM, Rodr\u00edguez M. A systematic review of medical students\u2019 and professionals\u2019 attitudes and knowledge regarding medical cannabis. J Cannabis Res. 2021;3(1):47.","journal-title":"J Cannabis Res"},{"issue":"7","key":"450_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jcph.1387","volume":"59","author":"CM White","year":"2019","unstructured":"White CM. A review of human studies assessing Cannabidiol\u2019s (CBD) therapeutic actions and potential. J Clin Pharmacol. 2019;59(7):923\u201334.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"450_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/can.2021.0022","volume":"8","author":"B Worster","year":"2023","unstructured":"Worster B, Ashare RL, Hajjar E, Garber G, Smith K, Kelly EL. Clinician attitudes, training, and beliefs about cannabis: an interprofessional assessment. Cannabis Cannabinoid Res. 2023;8(3):547\u201356.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"450_CR47","doi-asserted-by":"publisher","first-page":"e2254752","DOI":"10.1001\/jamanetworkopen.2022.54752","volume":"6","author":"CA Zamarripa","year":"2023","unstructured":"Zamarripa CA, Spindle TR, Surujunarain R, Weerts EM, Bansal S, Unadkat JD, et al. Assessment of orally administered \u03949-tetrahydrocannabinol when coadministered with cannabidiol on \u03949-tetrahydrocannabinol pharmacokinetics and pharmacodynamics in healthy adults: a randomized clinical trial. JAMA Netw Open. 2023;6(2):e2254752\u2013e2254752.","journal-title":"JAMA Netw Open"},{"key":"450_CR48","doi-asserted-by":"publisher","first-page":"102675","DOI":"10.1016\/j.ctim.2021.102675","volume":"58","author":"Y Zolotov","year":"2021","unstructured":"Zolotov Y, Metri S, Calabria E, Kogan M. Medical cannabis education among healthcare trainees: a scoping review. Complement Ther Med. 2021;58:102675.","journal-title":"Complement Ther Med"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00450-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:30:29Z","timestamp":1785454229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-026-00450-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["450"],"URL":"https:\/\/doi.org\/10.1186\/s42238-026-00450-8","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was deemed exempt by the Johns Hopkins University School of Medicine Institutional Review Board (IRB) because it involved minimal risk as no personally identifiable information was collected. All participants were informed of the voluntary nature of the study before proceeding and consented to participate. All research was performed in accordance with relevant guidelines\/regulations and in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DSM reported being the owner of Sattva Medicine outside the submitted work. TRS has served as a consultant for Canopy Health Innovations Inc. and Spaulding Clinical. RV has received compensation as a consultant or scientific advisory board member from Charlotte\u2019s Web and Syqe Medical, Ltd. AGR is a paid scientific advisor to Otsuka Pharmaceutical Development & Commercialization Inc. and Psyence BioMed. AGR has received research funding from MicroDoz Therapy Inc., Mydecine Innovations Group Inc., Unlimited Sciences, the Council on Spiritual Practices, the Heffter Research Institute, NIH, and DoD. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"88"}}